SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending as escalating US-Iran conflict, including military engagements and attacks on critical oil infrastructure like the Ras Tanura refinery, fuels widespread market uncertainty. The community remains sharply divided between those predicting a major market downturn and dip-buyers expecting a rebound from geopolitical volatility.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Escalating Middle East tensions, following drone strikes on Saudi oil facilities and effective restrictions in the Strait of Hormuz, are sending crude prices soaring, leading the community to anticipate a significant short squeeze and parabolic rally for low-float energy play Indonesia Energy Corp.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil Corp is trending amidst surging oil prices driven by escalating Middle East tensions, including drone strikes on Saudi oil infrastructure and threats to the Strait of Hormuz. The community is heavily focused on potential short squeezes and the stock's low float, positioning it as a leading play in the volatile energy sector.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as escalating geopolitical tensions involving the US, Israel, and Iran spark intense community debate, with many divided between anticipating a significant market correction and a "buy the dip" mentality, while concerns over rising oil prices and market manipulation remain key talking points.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending as escalating Middle East tensions threaten global LNG supply routes like the Strait of Hormuz, leading to anticipation of surging gas prices and a significant short squeeze. The community highlights VG's strong Q4 performance and rapidly expanding capacity, believing the company is exceptionally positioned to capitalize on current market dynamics despite conservative future guidance.

United States Commodity Funds LLC - United States Oil Fund

United States Oil Fund

USO is trending due to escalating geopolitical tensions in the Middle East, with reports of US-Israeli strikes on Iran and retaliatory attacks leading to significant disruptions and increased war risk premiums for shipping through the critical Strait of Hormuz. The community is actively discussing the potential for a substantial oil price spike and the broader implications for global supply, overshadowing OPEC+'s modest output increase.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line Holdings is experiencing a surge of interest after activist investor Elliott Management disclosed a substantial stake, advocating for governance and strategic overhauls to improve the company's lagging performance against rivals. The community is buzzing with optimism for a potential turnaround and a new CEO's impact, despite past frustrations and concerns over broader market conditions.

Exxon Mobil Corp. engages in the exploration, development, and distribution of oil, gas, and petroleum products. It operates through the following segments: Upstream, Energy Products, Chemical Products, and Specialty Products. The Upstream segment organizes the exploration of crude oil and natural gas. The Energy Products segment includes fuels, aromatics, and catalyst and licensing. The Chemical Products segment offers petrochemicals. The Specialty Products segment provides finished lubricants, basestocks and waxes, synthetics, and elastomers and resins. The company was founded by John D. Rockefeller in 1882 and is headquartered in Spring, TX.

Exxon Mobil Corp.

Exxon Mobil Corp

Exxon Mobil (XOM) is trending as escalating geopolitical tensions in the Middle East, particularly around potential disruptions to oil flows through the Strait of Hormuz, are driving a significant surge in crude prices across global markets. The community is actively debating whether this reflects a sustainable surge for energy stocks, with many buying on expectations of higher oil prices, while others anticipate a temporary spike followed by a pullback.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is a key talking point as recent military actions attributed to its namesake, former President Trump, spur intense community debate on geopolitical stability, rising energy prices, and potential market impacts.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is rallying on an earnings beat and highly optimistic revenue guidance, fueled by surging demand for its 800G optical transceivers critical for AI data centers. The community is sharply divided, with bulls highlighting its essential role in AI infrastructure and aggressive growth outlook, while skeptics point to historical over-guidance and concerns over a recent stock offering.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Olema Pharmaceuticals CEO Touts Palazestrant Edge as Oral SERDs Shake Out at Conference

Olema Pharmaceuticals (NASDAQ:OLMA) President and CEO Sean Bohen said the company believes the emerging oral selective estrogen receptor degrader (SERD) class has proven its value over the past year...

Olema Pharmaceuticals CEO Teases Fall OPERA-01 Readout, Q2 KAT6 Data and CFO/COO Exit

Olema Pharmaceuticals (NASDAQ:OLMA) is focused on developing endocrine therapies aimed at improving outcomes for patients with estrogen receptor (ER)-positive, HER2-negative breast cancer, CEO Sean...

This Olema Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday

Olema Pharmaceuticals (NASDAQ:OLMA) Now Covered by Analysts at Stifel Nicolaus

Stifel Nicolaus assumed coverage on Olema Pharmaceuticals in a research report on Wednesday. They set a "buy" rating and a $48.00 price target for the company...

Candriam S.C.A. Increases Stock Position in Olema Pharmaceuticals, Inc. $OLMA

Candriam S.C.A. raised its stake in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Free Report) by 46.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange...

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Given Consensus Rating of "Moderate Buy" by Analysts

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) has been given an average rating of "Moderate Buy" by the ten brokerages that are currently covering the company, MarketBeat reports. One...

Short Interest in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Decreases By 12.5%

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) was the recipient of a large decrease in short interest in January. As of January 15th, there was short interest totaling 9,100,561 shares...

Olema Pharmaceuticals (NASDAQ:OLMA) Trading 7.7% Higher - Here's What Happened

Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Up 7.7% - Here's Why...

Olema Pharmaceuticals (NASDAQ:OLMA) Director Sells 10,000 Shares

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) Director Cyrus Harmon sold 10,000 shares of Olema Pharmaceuticals stock in a transaction on Tuesday, January 20th. The stock was sold at an...

Olema Pharmaceuticals (NASDAQ:OLMA) Director Cyrus Harmon Sells 10,000 Shares

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) Director Cyrus Harmon sold 10,000 shares of the firm's stock in a transaction that occurred on Tuesday, January 20th. The shares were sold...

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.

Olema Pharmaceuticals Inc

Day trading

Swing trading

Long-term investing

Sitting in cash

Markets have been volatile, with macro headlines and earnings driving sharp moves. How are you positioning right now?

Drop your approach below 👇

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.51	--	--	N/A
Q3 '25	-$0.47	-$0.49	-3.24%	MISSED
Q2 '25	-$0.42	-$0.51	-20.50%	MISSED
Q1 '25	-$0.49	-$0.36	25.77%	BEAT
Q4 '24	-$0.63	-$0.51	19.07%	BEAT

OLMA
Olema Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest OLMA News

OLMAOlema Pharmaceuticals Inc